{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:23:18Z","timestamp":1791937398018,"version":"4.3.4"},"reference-count":20,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":172,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Internal Medicine"],"published-print":{"date-parts":[[2001,7]]},"abstract":"<jats:p>Lamy O, Jenzer\u2010Closuit A, Burckhardt P (University Hospital, Lausanne, Switzerland). Hypercalcaemia of malignancy: an undiagnosed and undertreated disease. <jats:italic>J Intern Med<\/jats:italic> 2001; <jats:bold>250:<\/jats:bold> 73\u201379.<\/jats:p><jats:p> <jats:bold>Background.<\/jats:bold>\u2002Hypercalcaemia of malignancy, a relatively frequent phenomenon, seems to be insufficiently recognized and treated. Its symptoms are not specific, but they affect the quality of life.<\/jats:p><jats:p> <jats:bold>Methods.<\/jats:bold>\u2002A prospective study to analyse the influence of symptoms caused by hypercalcaemia on the decision of the admitting physician, the motivation for treatment, and the effect of the treatment on the given symptoms in hospitalized patients with oncologic disease in progression, where confounding causes of similar symptoms such as cerebral metastasis, radiotherapy, treatment with opioids, etc., were excluded.<\/jats:p><jats:p> <jats:bold>Results.<\/jats:bold>\u2002A total of 71 patients, mean age 65\u2003+ 11\u2003years, fulfilled the strict inclusion criteria. About 42% were hospitalized because of symptoms caused by hypercalcaemia, but none of the medical reports mentioned hypercalcaemia as reason for hospitalization. Specific antihypercalcaemic therapy was given to only 37% of patients, and only 25% got an adequate rehydratation. Antihypercalcaemic treatment was guided by the severity of hypercalcaemia (&gt;3.00\u2003mmol\u2003L<jats:sup>\u20131<\/jats:sup>), not by the symptoms. Polyuria\u2010polydipsia, nausea\u2010vomiting and constipation were correlated with hypercalcaemia. These symptoms, as well as confusion\u2010stupor and bone pains improved significantly when calcaemia was normalized. Patients with calcaemia normalized returned home most frequently (<jats:italic>P\u2003<\/jats:italic>&lt;\u20030.03).<\/jats:p><jats:p> <jats:bold>Conclusions.<\/jats:bold>\u2002Malignant hypercalcaemia remains mostly undiagnosed in medical praxis. Specific treatment occurs in too small fractions of the patients. As the normalization of calcaemia significantly improves the symptoms because of hypercalcaemia and the quality of life, rapid rehydration and specific calcium lowering treatments should be part of palliative measures in all patients with malignant hypercalcaemia.<\/jats:p>","DOI":"10.1046\/j.1365-2796.2001.00859.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T06:13:44Z","timestamp":1047449624000},"page":"73-79","source":"Crossref","is-referenced-by-count":30,"title":["Hypercalcaemia of malignancy: an undiagnosed and undertreated disease"],"prefix":"10.1111","volume":"250","author":[{"given":"O.","family":"Lamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Jenzer\u2010Closuit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Burckhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.63.743.745"},{"key":"e_1_2_5_3_2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/00365513.1991.11978687","article-title":"Awareness of hypercalcaemia in a hospital population?","volume":"51","author":"Froelich A","year":"1991","journal-title":"Scand J Clin Lab Invest"},{"key":"e_1_2_5_4_2","first-page":"405","article-title":"Hypercalcaemia\u2013A hospital survey","volume":"196","author":"Fisken RA","year":"1980","journal-title":"Q J Med"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)90071-4"},{"key":"e_1_2_5_6_2","first-page":"2017","article-title":"Hypercalci\u00e4mie bei hospitalisierten Patienten","volume":"111","author":"Burckhardt E","year":"1981","journal-title":"Schweiz Med Wschr"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1986.tb02795.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930215)71:4<1309::AID-CNCR2820710423>3.0.CO;2-M"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.298.6686.1468"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1980.01380060012004"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-112-7-499"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1159\/000180580"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196907102810201"},{"key":"e_1_2_5_14_2","unstructured":"Kaufmann DidisheimN.D\u00e9finition de l\u2019intervalle de r\u00e9f\u00e9rence de la calc\u00e9mie dans une population hospitali\u00e8re. Medical thesis University of Lausanne Switzerland1989."},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(18)30170-1"},{"key":"e_1_2_5_16_2","unstructured":"LeBoffMS&BrownEM.Clinical disorders of calcium metabolism. In: Hare JW ed.Signs and Symptoms in Endocrine and Metabolic Disorders.London Philadelphia: J.B. Lippincott Co. 1986; 224\u201338."},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0936-6555(94)80057-X"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199602223340802"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199612123352401"},{"key":"e_1_2_5_20_2","unstructured":"SuttonRAL&DirksJH.Disturbances of calcium and magnesium metabolism. In: Brenner BM Rector FC eds.The Kidney.Philadelphia: WB Saunders Company 4th edn 1991; 841\u201379."},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0248-8663(05)81159-2"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2796.2001.00859.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2796.2001.00859.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T00:34:25Z","timestamp":1697330065000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2796.2001.00859.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["10.1046\/j.1365-2796.2001.00859.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2796.2001.00859.x","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,7]]}}}